跳至主要内容
临床试验/NCT00254475
NCT00254475已完成3 期

A Study to Evaluate the Efficacy of the Valsartan/Simvastatin Combinations 160/20mg up Titrated to 320/20mg Versus 160/40mg up Titrated to 320/40mg in Patients With Both Essential Hypertension and Hypercholesterolemia

Novartis2 个研究点 分布在 2 个国家目标入组 871 人开始时间: 2005年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Novartis
入组人数
871
试验地点
2
主要终点
Low density lipoproteins after 6 weeks

研究概览

简要总结

The purpose of this study is to provide data on the dose response of simvastatin in lowering LDL-C when it is co-administered with valsartan in patients with both essential hypertension and hypercholesterolemia. The primary objective of the study will be to show that the combination of valsartan 160mg/simvastatin 40mg has superior efficacy compared to the combination of valsartan 160mg/simvastatin 20mg in percentage change from baseline in LDL-C.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Elevated LDL-Cholesterol
  • •Essential hypertension

排除标准

  • •Severe Hypertension
  • •Prior or known muscular or neuromuscular disease of any type
  • •A history of cardiovascular disease
  • •Hypertension or hypercholesterolemia due to secondary causes
  • •Uncontrolled diabetes or insulin treatment
  • •Evidence of hepatic or renal disease
  • •Other protocol-defined exclusion criteria may apply

结局指标

主要结局

Low density lipoproteins after 6 weeks

次要结局

  • Lipid profile at 6, 12 wks
  • BP < 140/90 mmHg in non diabetics, or < 130/80 mmHg in diabetics, and LDL-C < 2.6, 3.4 or 4.1 mmol/l based on risk group at 6, 12 wks
  • SBP < 140 mmHg in non diabetics, < 130 mmHg in diabetics, or 20 mmHg decrease in SBP from baseline and DBP < 90 mmHg in non diabetics, DBP < 80 mmHg in diabetics, or 10 mmHg decrease in DBP from baseline at 6, 12 wks
  • Systolic and diastolic bp at 6, 12 wks
  • Serious/adverse events, labs, physical exams, vitals up to 12 wks

研究者

发起方
Novartis
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验